Guardian Pharmacy Services

GRDN

Market cap $2.42B

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release first quarter 2026 financial results after market close on Wednesday, May 6, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (833) 461-5787 for participants located in the United Sta.

GRDN and ESCA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 10th, 2026.

ESCA, GRDN, TPST, ASTE and ECG have been added to the Zacks Rank #1 (Strong Buy) List on April 10th, 2026.

Guardian Pharmacy Services (GRDN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Guardian Pharmacy (GRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

DOO, GRDN and PR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 30th, 2026.

NESR, BLBD, PR, GRDN and LCUT have been added to the Zacks Rank #1 (Strong Buy) List on March 30th, 2026.

Do you have more faith in DuPont analysis than in simple ROE calculation? MYR Group (MYRG), Blue Bird (BLBD), Guardian Pharmacy Services (GRDN), Ubiquiti (UI) and Everus Construction Group Inc. (ECG).

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the pricing of its upsized underwritten public offering (the “Offering”) of 6,000,000 shares of its Class A common stock at a public offering price of $31.00 per share, of which 4,980,000 shares will be sold by certain selling stockholders and 1,020,000 shares will be issued and sold by Guardian as part of a non-dilutive “synthetic secondary” transaction, as described below. In addition, the sel.

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the launch of a proposed underwritten public offering (the “Offering”) of 5,000,000 shares of its Class A common stock, consisting of 3,980,000 shares being offered by certain selling stockholders and 1,020,000 newly issued shares being offered by Guardian as part of a non-dilutive “synthetic secondary” transaction, as described below. In addition, the selling stockholders intend to grant the un.